Meet the Advisory Board: Part One
Oncology Professional Care is proud to be supported by an expert advisory board, representative of all members of the multi-disciplinary team, who support the development of the programme and speaker faculty. We have invited some of the most senior and innovative leaders transforming the patient pathway in oncology today to join this committee, ensuring we can deliver true value to all our attendees and partners.
Our advisory board is already helping us to refine the direction of the event and agenda, as well as sharing insights into how we can build out our community. We hope our advisory board will be the cornerstone of our Oncology community, and that we can work with our members to make sure that we are delivering true value to all our attendees and partners.
Here’s our first round of introductions to the Oncology Professional Care Advisory Board 2024…
Geoff Bellingan - Medical Director, University College London Hospitals (UCLH)
Geoff is SRO for the North Central London Cancer Alliance and one of the leaders of the program of centralisation of surgery for rarer cancers across North Central and East London over the last 5 years. He is SRO for the new Grafton Way Building at UCLH - the site for the second of the two National proton beam therapy units - opening later this year. The building also houses Europe’s largest haemoncology centre. As medical director at UCLH Geoff and has led the development of cancer there for the last ten years and an academic has ensured the cancer agenda is closely aligned with biomedicine at UCL and there is a strong theme of innovation and trials to underpins the service.
Emma Hallam - Consultant Therapeutic Radiographer, Nottingham University Hospitals NHS Trust
Emma is a Macmillan Consultant Therapeutic Radiographer. In 2013 she developed and now leads the award winning Macmillan Nottingham Radiotherapy Late Effects Clinic. This bespoke service, the first if its kind within the UK helps patients with any physical or psychological late effects that patients may have as a consequence from their treatment. In 2019 she developed the service further to include the follow up of head and neck radiotherapy patients using patient reported outcome measures and digital technology and it is here where Emma helps to provide rehabilitation, identify early lymphoedema and other late effects with the intention of providing help and support before these consequences have a negative impact on the patient’s quality of life. Offering a holistic approach, helping patients live well with and beyond cancer and education on late effects to both patients and health professionals is Emma’s key focus and area if interest.
Majid Kazmi - Director of Innovation for Cancer and Surgery and Deputy Medical Director, Guy’s and St Thomas’ NHS Foundation Trust
Majid Kazmi, B.Med.Biol, MD ChB (comm), FRCP, FRCPath, has a national profile in myeloma and bone marrow (stem cell) transplantation as well as clinical leadership in cancer. Majid is the UK lead for the EBMT (European group for Blood and Marrow Transplantation) for auto-immune disorders and has performed the largest number of these transplants in the UK. He has been involved in writing the UK myeloma and amyloidosis guidelines and is an invited speaker nationally and internationally.
Sandra Dyer - Primary Care Lead Nurse, Transforming Cancer Services Team for London
Sandra is Primary Care Lead Nurse for Transforming Cancer Services Team for London (TCST), a part of the Transformation Partners for Health. This is a pan London role developing the role of primary care nurses around personalised care and cancer, more information is available on the TCST website Her current work programme builds on a previous programme of work funded by Macmillan Cancer support in SW London ( Macmillan Primary Care Nursing Project.) She has previously worked in a Prostate Cancer UK funded role at TCST and to develop a stratified follow up model for primary care for men with stable prostate cancer. Sandra has extensive experience in the care of patients with long term conditions having worked in many community/primary care settings and remains in clinical practice as an Advanced Nurse Practitioner in primary care. She has a BSc in Community Nursing/SPQ District Nurse, and MSc in Advanced Nursing Practice and is a V300 Independent Prescriber. Sandra is passionate about developing primary care nursing and advanced practice to ensure that the unique value that nursing brings to healthcare is both recognised and utilised, particularly in relationship to cancer survivorship. She has an interest in applied healthcare research and is currently seeking funding for research to explore nurse led cancer care reviews in primary care and improved patient experience.
Stephen Allen - Patient Representative, Tackle Prostate Cancer
Stephen underwent radical surgical treatment for prostate cancer 15 years ago, experiencing a number of the complications associated with major surgery. He has been a volunteer with Tackle Prostate Cancer and Prostate Cancer UK for many years both raising awareness and being involved in education of patients and Healthcare professionals. He has talked with many patients over the years and shared their experiences. He is currently the patient representative for Tackle and represents patients on a number of national bodies such as NICE, SMC and NPCA, believing the voice of patients in every arena is vital. He is also a retired medic but will always be a patient first and a doctor second.
Anthony Cunliffe - National Lead GP Adviser, Macmillan Cancer Support
Dr. Anthony Cunliffe has been a GP for 13 years and currently practices part-time in South London. He subsequently became the lead GP Advisor for London and, more recently, the joint National Clinical Adviser for Primary Care. Anthony is also the joint clinical director for the South East London Cancer Alliance.
And that concludes part one of our announcements. Stay tuned for the second instalment of our Advisory Board announcements…